STING Agonists as Cancer Therapeutics

SIMPLE SUMMARY: Immunotherapies have revolutionized the field of cancer therapeutics, yet a substantial subset of patients fail to respond. Recent efforts have focused on identifying targets that could elicit or augment anti-tumor immune responses. One such novel target is STING or stimulator of int...

Descripción completa

Detalles Bibliográficos
Autores principales: Amouzegar, Afsaneh, Chelvanambi, Manoj, Filderman, Jessica N., Storkus, Walter J., Luke, Jason J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198217/
https://www.ncbi.nlm.nih.gov/pubmed/34070756
http://dx.doi.org/10.3390/cancers13112695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198217/
https://www.ncbi.nlm.nih.gov/pubmed/34070756
http://dx.doi.org/10.3390/cancers13112695

Ejemplares similares